Biogen Idec's Next Steps

May 30, 2011

May 31, 2011 | Since George Scangos took the lead at Biogen Idec, he has cut 13% of the company's gobal workforce, dumped more than a dozen drug development projects, and halted the company's move from Cambridge to Weston, Mass. The company it turning its interest to hemophilia and Lou Gehrig's disease and is searching out partners. Boston Globe